AZ’s Evusheld Receives World-First Approval As COVID-19 Treatment, In Japan
Contrast With UK Decisions
Japan has approved Evusheld for both the prevention of infection in people who have not been exposed to the virus and, for the first time globally, as a treatment. The country's government will purchase 300,000 units from AZ amid global supplies that have been limited due to the surging need for the drug.
